Literature DB >> 21478037

Factors associated with downgrading in patients with high grade prostate cancer.

Jared M Whitson1, Sima P Porten, Janet E Cowan, Jeff P Simko, Matthew R Cooperberg, Peter R Carroll.   

Abstract

OBJECTIVE: To determine the factors associated with downgrading between biopsy and prostatectomy in the contemporary era using extended-template biopsy techniques.
MATERIALS AND METHODS: The UCSF Urologic Oncology Database was used to identify subjects diagnosed with high grade prostate cancer (primary pattern 4 or 5) in at least one core on extended-pattern biopsy. Multivariable logistic regression analysis was performed to identify independent factors associated with downgrading at radical prostatectomy, defined as a change from primary pattern 4 or 5 to primary pattern 3.
RESULTS: Downgrading occurred in 68 (34%) of 202 subjects who met the study criteria. Fourteen (47%) of 30 subjects with ≤25% of cores that were high grade and 9 (43%) of 21 subjects with <10% of total tissue containing cancer were downgraded. In a multivariable model, patients with mixed grade cores had much higher odds of downgrading than those with all high grade cores (OR 3.0 95% 1.3-7.1), P < 0.01). The proportion (per 10% increment) of positive cores containing high grade cancer (OR 0.8 95% CI 0.7-0.9 P < 0.01) and the percent (per 10% increment) of total tissue containing cancer (OR 0.7 95% CI 0.6-0.9 P = 0.01) were significantly associated with lower odds of downgrading.
CONCLUSIONS: Downgrading following radical prostatectomy is a common event. Biopsy over-grading may preclude men from active surveillance or lead to unnecessary lymphadenectomy, excess radiation, or prolonged hormone therapy. The proportion of positive biopsy cores that are high grade and the percent of total tissue containing cancer should be incorporated into decision making.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478037     DOI: 10.1016/j.urolonc.2011.02.010

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  5 in total

1.  Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.

Authors:  Tatsuo Gondo; Hedvig Hricak; Evis Sala; Junting Zheng; Chaya S Moskowitz; Melanie Bernstein; James A Eastham; Hebert Alberto Vargas
Journal:  Eur Radiol       Date:  2014-08-07       Impact factor: 5.315

2.  The impact of surgical downgrading on prostate cancer recurrence: systematic review and analysis of a multiethnic population.

Authors:  Denzel Zhu; William Shyr; Michelle Toker; Ethan Fram; Jinrong Cheng; Evan Z Kovac; Ilir Agalliu; Ahmed Aboumohamed; Kara L Watts
Journal:  World J Urol       Date:  2021-11-30       Impact factor: 4.226

3.  Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer.

Authors:  Tatsuo Gondo; Bing Ying Poon; Kazuhiro Matsumoto; Melanie Bernstein; Daniel D Sjoberg; James A Eastham
Journal:  BJU Int       Date:  2014-08-13       Impact factor: 5.588

4.  The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer.

Authors:  John G Phillips; Ayal A Aizer; Ming-Hui Chen; Danjie Zhang; Michelle S Hirsch; Jerome P Richie; Clare M Tempany; Stephen Williams; John V Hegde; Marian J Loffredo; Anthony V D'Amico
Journal:  Clin Genitourin Cancer       Date:  2014-03-03       Impact factor: 2.872

Review 5.  Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.

Authors:  A Marije Hoogland; Charlotte F Kweldam; Geert J L H van Leenders
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.